Both in Pharmaceuticals
PERRIGO vs Septerna
Over the past year PRGO returned −20.2% and SEPN returned +135.9%; their daily moves had a correlation of 0.04.
PRGO −20.2% SEPN +135.9%Growth of $1, one year, split-adjusted
| Metric | PRGO | SEPN |
|---|---|---|
| Price | $16.38 | $47.29 |
| Market cap | $2.27B | $2.21B |
| Today | +4.30% | +8.22% |
| 1 month | +17.0% | +32.6% |
| 6 months | +33.6% | +91.4% |
| Year to date | +17.6% | +69.6% |
| 1 year | −20.2% | +135.9% |
| Revenue growth (YoY) | −3.2% | +22375.6% |
| Gross margin | 30.7% | 100.0% |
| Net margin | 7.3% | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 22.3× |
| Net cash | -$2.90B | $372.3M |
| Dividend yield | 7.08% | — |
| Volatility (60d) | 40.9% | 48.2% |
| Short % of float | 17.5% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).